Chemical Compound

Fosaprepitant dimeglumine

CAS Registry Number 265121-04-8
Fosaprepitant dimeglumine chemical structure
Primary Record

Fosaprepitant dimeglumine

In stock
5,107 g
Purity
99.3 %
CAS
265121-04-8

Compound Identifiers & Properties

CAS
265121-04-8
PubChem CID
135564864
SMILES
C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H](N(CCO2)CC3=NN(C(=O)N3)P(=O)(O)O)C4=CC=C(C=C4)F.CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O.CNC[C@@H]([C@H]([C@@H]([C@@H](CO)O)O)O)O
Canonical SMILES
CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.C[C@@H](O[C@H]1OCCN(Cc2nn(P(=O)(O)O)c(=O)[nH]2)[C@H]1c1ccc(F)cc1)c1cc(C(F)(F)F)cc(C(F)(F)F)c1

Names & Synonyms

  • Fosaprepitant dimeglumine
  • Ivemend
  • 265121-04-8
  • Emend
  • Fosaprepitant meglumine
  • Fosaprepitant
  • Aprepitant
  • FOCINVEZ
  • Fosaprepitant dimeglumine salt
  • Proemend (TN)
  • Emend for injection
  • Fosaprepitantdimeglumine
  • MK-0517
  • RefChem:57106
  • Fosaprepitant (dimeglumine)
  • D35FM8T64X
  • Fosaprepitant dimeglumine?
  • UNII-D35FM8T64X
  • Fosaprepitantdimegluminesalt
  • Fosaprepitant dimeglumine [USAN]
  • CHEBI:64311
  • DTXSID50181095
  • Fosaprepitant (as dimeglumine)
  • Fosaprepitant meglumine (JAN)
  • MFCD23102059
  • VRQHBYGYXDWZDL-OOZCZQCLSA-N
  • AMY380
  • orb1307445
  • CHEMBL1201782
  • SCHEMBL29358080
  • C37H56F7N6O16P
  • DTXCID60103586
  • Fosaprepitant dimeglumine (USAN)
  • GLXC-05196
  • HMS3885C05
  • HY-14407AR
  • EX-A1255
  • ARD189163
  • FOSAPREPITANT MEGLUMINE [JAN]
  • HY-14407A
  • NP2602
  • s3038
  • FOSAPREPITANT DIMEGLUMINE [MI]
  • AKOS025401855
  • AKOS026751492
  • MK 0517 (Fosaprepitant dimeglumine)
  • ACN-037209
  • CCG-270607
  • CS-1761
  • FD46503
  • Fosaprepitant (dimeglumine) (Standard)
  • FOSAPREPITANT MEGLUMINE [MART.]
  • FOSAPREPITANT MEGLUMINE [WHO-DD]
  • C23H22F7N4O6P.2C7H17NO5
  • FOSAPREPITANT DIMEGLUMINE [VANDF]
  • AC-26397
  • Fosaprepitant dimeglumine (as dimeglumine)
  • SC-94648
  • SY116089
  • SW219389-1
  • X3475
  • A11069
  • C74373
  • D06597
  • FOSAPREPITANT DIMEGLUMINE [ORANGE BOOK]
  • A855468
  • F979755
  • L-758298
  • Q27895904
  • (2R,3R,4R,5S)-6-(Methylamino)hexane-1,2,3,4,5-pentaol ((3-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonate)(2:1)
  • D-GLUCITOL, 1-DEOXY-1-(METHYLAMINO)-, (3-(((2R,3S)-2-((1R)-1-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)ETHOXY)-3-(4-FLUOROPHENYL)-4-MORPHOLINYL)METHYL)-2,5-DIHYDRO-5-OXO-1H-1,2,4-TRIAZOL-1-YL)PHOSPHONATE (2:1) (SALT)
  • (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentaol hemi((3-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-5-oxo-2,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonate)
  • (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentaol hemi((3-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonate)
  • (3-{[(2R,3S)-2-{(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-5-oxo-2,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid--1-deoxy-1-(methylamino)-D-glucitol (1/2)
  • (3-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonic acid--1-deoxy-1-(methylamino)-D-glucitol (1/2)
  • [3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-5-oxo-4H-1,2,4-triazol-1-yl]phosphonic acid;(2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol
  • 1-Deoxy-1-(methylamino)-D-glucitol [3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]m ethyl]-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]phosphonate
  • 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-2-phosphonato-1H-1,2,4-triazol-3-one;methyl-[(2S,3R,4R,5R)-2,3,4,5,6-pentahydroxyhexyl]ammonium
  • BIS(1-DEOXY-1-(METHYLAMINO)-D-GLUCITOL) (3-(((2R,3S)-2-((1R)-1-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)ETHOXY)-3-(4-FLUOROPHENYL)-4-MORPHOLINYL)METHYL)-2,5-DIHYDRO-5-OXO-1H-1,2,4-TRIAZOL-1-YL)PHOSPHONATE
  • bis[1-deoxy-1-(methylazaniumyl)-D-glucitol] (3-{[(2R,3S)-2-{(1R,)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-5-oxo-4,5-dihydro-1H-1,2,4-triazol-1-yl)phosphonate
  • D-Glucitol, 1-deoxy-1-(methylamino)-, (3-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4- morpholinyl)methyl)-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl)phosphonate (2:1) (salt)
  • D-Glucitol, 1-deoxy-1-(methylamino)-, [3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]phosphonate (2:1); D-Glucitol, 1-deoxy-1-(methylamino)-, [3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]phosphonate (2:1) (salt) (9CI); Phosphonic acid, [3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]-, compd. with 1-deoxy-1-(methylamino)-D-glucitol (1:2) (9CI); Fosaprepitant di(N-methylglucamine); Fosaprepitant dimeglumine; MK 0517
  • Phosphonic acid, (3-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl)-, compd. with 1-deoxy-1-(methylamino)-D-glucitol (1:2)